Center expands drug import gateways under Rule 43A, aiming to ease pharma logistics, improve cargo movement and reduce clearance delays.
Granules India delivers a robust second-quarter performance in FY27 as net profit climbs 39% to Rs 182 crore while revenue advances 20% to Rs 1,560 crore.
Dr Reddy’s lenacapavir gets USFDA nod for HIV prevention, advancing affordable twice-yearly injections and expanding access across 120 low- and middle-income countries.
Fresenius is expanding its biosimilar manufacturing strategy through a WuXi Biologics partnership, gaining access to 37 candidates and strengthening its long-term biopharma ambitions.
Patan's new cancer hospital adds Rs 22 crore radiotherapy capacity and free PET scans for eligible beneficiaries, raising hopes of better regional cancer care access.
RPG Life Sciences' 500 crore acquisition bet could redefine its API business, expand manufacturing capacity and accelerate export growth.
Haryana's Private Healthcare Integration challenge highlights the gap between public healthcare mapping and private-sector participation in India's expanding digital health infrastructure.
Weight loss injections may ease PMOS symptoms and improve metabolic health, but experts warn they cannot cure underlying hormonal imbalances.
Sun Pharma gains CDSCO approval for oral semaglutide tablets, marking its entry into India’s competitive oral GLP-1 market.
Sun Pharma’s Q2 profit falls as acquisition costs rise, despite revenue growth and stronger operating performance across key business segments.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
